Back
Vor Biopharma Stock Price Chart
Top investors are buying this "unlisted" stock
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
13
VOR
Vor Biopharma
Last Price:
$0.17
Seasonality Move:
-38.94%
7 Day Trial
ALL ACCESS PASS
$
7
The key to a $1.3T opportunity
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VOR is experiencing selling pressure, which indicates risk of future bearish movement.
Vor Biopharma Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.38 | Sell |
| 20-day SMA: | 0.57 | Sell |
| 50-day SMA: | 0.69 | Sell |
| 200-day SMA: | 0.92 | Sell |
| 8-day EMA: | 0.33 | Sell |
| 20-day EMA: | 0.5 | Sell |
| 50-day EMA: | 0.69 | Sell |
| 200-day EMA: | 1.04 | Sell |
Vor Biopharma Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.14 | Sell |
| Relative Strength Index (14 RSI): | 16.94 | Sell |
| Chaikin Money Flow: | -4722920 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.39 - 0.77) | Sell |
| Bollinger Bands (100): | (0.63 - 1.35) | Sell |
Vor Biopharma Technical Analysis
| Apr 30 | May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 30 | 01 | 02 | 05 | 06 | 07 | 08 | 09 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Vor Biopharma Stock
Is Vor Biopharma Stock a Buy?
-
Vor Biopharma share price is 0.16 while VOR 8-day simple moving average is 0.38, which is a Sell signal.
-
The stock price of VOR is 0.16 while Vor Biopharma 20-day SMA is 0.57, which makes it a Sell.
-
Vor Biopharma 50-day simple moving average is 0.69 while VOR share price is 0.16, making it a Sell technically.
-
VOR stock price is 0.16 and Vor Biopharma 200-day simple moving average is 0.92, creating a Sell signal.
VOR Technical Analysis vs Fundamental Analysis
Sell
13
Vor Biopharma (VOR)
is a Sell
Is Vor Biopharma a Buy or a Sell?
-
Vor Biopharma stock is rated a SellThe current Vor Biopharma [VOR] share price is $0.16. The Score for VOR is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.
Vor Biopharma Stock Info
Market Cap:
20M
Price in USD:
0.16
Share Volume:
4.7M
Vor Biopharma 52-Week Range
52-Week High:
1.87
52-Week Low:
0.13
Sell
13
Vor Biopharma (VOR)
is a Sell
Vor Biopharma Share Price Forecast
-
What is the Vor Biopharma stock price today?The Vor Biopharma stock price is 0.16 USD today.
-
Will VOR stock go up or go down?Vor Biopharma> share price is forecast to RISE/FALL based on technical indicators
-
Is Vor Biopharma overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Vor Biopharma is overvalued.
Is Vor Biopharma Stock a Buy?
-
Vor Biopharma share price is 0.16 while VOR 8-day exponential moving average is 0.33, which is a Sell signal.
-
The stock price of VOR is 0.16 while Vor Biopharma 20-day EMA is 0.50, which makes it a Sell.
-
Vor Biopharma 50-day exponential moving average is 0.69 while VOR share price is 0.16, making it a Sell technically.
-
VOR stock price is 0.16 and Vor Biopharma 200-day simple moving average is 1.04, creating a Sell signal.
Fundamental Analysis of Vor Biopharma
Is Vor Biopharma a good investment?
-
Analysts estimate an earnings increase this quarter of $0.30 per share, an increase next quarter of $0.02 per share, an increase this year of $0.88 per share, and an increase next year of $0.25 per share.
Technical Analysis of Vor Biopharma
Should I short Vor Biopharma stock?
-
VOR Moving Average Covergence Divergence (MACD) indicator is -0.14, suggesting Vor Biopharma is a Sell
-
Vor Biopharma Relative Strength Index (RSI) is 16.94, which suggest Vor Biopharma is oversold
-
The Bollinger Bands (25) for Vor Biopharma is (0.39 - 0.77), which suggest Vor Biopharma is a Sell
-
The Bollinger Bands (100) for Vor Biopharma is (0.63 - 1.35), which suggest Vor Biopharma is a Sell
* Vor Biopharma stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.